| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 09/25/2008 | US20080233112 Treatment of Diseases |
| 09/25/2008 | US20080233105 Compositions and methods for preventing or treating a viral infection |
| 09/25/2008 | US20080233095 Method for obtaining antigen-specific tr1 regulatory lymphocytes |
| 09/25/2008 | US20080233081 Pro-angiogenic peptides |
| 09/25/2008 | US20080233078 Therapeutic polyesters and polyamides |
| 09/25/2008 | CA2682259A1 Compound that is a dual inhibitor of enzymes pde7 and/or pde4, pharmaceutical compositions and uses thereof |
| 09/25/2008 | CA2681341A1 Apoptotic anti-ige antibodies |
| 09/25/2008 | CA2680397A1 Novel adenine compound |
| 09/25/2008 | CA2679138A1 Amino-pyridine derivatives as s1p1/edg1 receptor agonists |
| 09/25/2008 | CA2671303A1 Chymosin for the prevention and treatment of gastrointestinal disorders |
| 09/25/2008 | CA2653226A1 Liposomes and immunopotentiating compositions containing the same |
| 09/24/2008 | EP1971403A1 Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 09/24/2008 | EP1971402A1 Immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant |
| 09/24/2008 | EP1971369A2 Combination of anticholinergics, glucocorticoids, beta2-agonists, pde4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
| 09/24/2008 | EP1971360A2 Treatment of multiple sclerosis using interferon-tau |
| 09/24/2008 | EP1971351A2 Mineral-herbal preparation consisting of zeolite and astragalus membranaceus root extract to treat allergies |
| 09/24/2008 | EP1601374B1 Compositions and methods for diagnosing and treating an inflammation |
| 09/24/2008 | EP1537096B1 Derivatives of dioxane-2-alkyl carbamates, preparation method thereof and application of same in therapeutics |
| 09/24/2008 | EP1513520B1 Substituted pyrrolines as kinase inhibitors |
| 09/24/2008 | EP1446139B1 Pharmaceutical composition containing soluble fcgamma receptor iib |
| 09/24/2008 | CN101273047A Thieno[2,3-B]pyridine-5-carbonitriles as protein kinase inhibitors |
| 09/24/2008 | CN101273013A Sulfonamide derivative having PGD2 receptor antagonistic activity |
| 09/24/2008 | CN101272780A DPP IV inhibitor for use in the treatment of autoimmune diseases and graft rejection |
| 09/24/2008 | CN101270379A Preparation method for abstracting collagen helical peptide from wood frog tissue |
| 09/24/2008 | CN101270167A Method for preparing lilium brownii polysaccharide for reinforcing phylactic power |
| 09/24/2008 | CN101269220A Rapamycin eye-in implantation type medicine release system with bletilla striata glue as carrier |
| 09/24/2008 | CN101269219A Method for preparing oligose absorbent charcoal carrier sustained-release agent |
| 09/24/2008 | CN101269198A Pure Chinese medicine preparation for preventing and treating enteron disease and improving self phylactic power, and preparation method thereof |
| 09/24/2008 | CN101269164A Method of preparing virus bacterium blood serum Chinese aloe vaccine powder preparation and oral liquid for livestock, poultry biology and aquatic animal |
| 09/24/2008 | CN101269095A Supercritical combined processing method of ganoderma lucidum and ganoderma lucidum spore |
| 09/24/2008 | CN101269093A Wall-breaking abstraction melissa powder oil and fat method with supercritical carbonic anhydride |
| 09/24/2008 | CN101269089A Application of CTLA4Ig gene modified medulla mesenchyma stem cell |
| 09/24/2008 | CN101269088A Stem cell preparation for preventing and treating chronic graft versus host disease |
| 09/24/2008 | CN101269038A Chlorpheniramine maleate sustained-release dropping pill and preparation method thereof |
| 09/24/2008 | CN101268848A Dew concentration beverage |
| 09/24/2008 | CN101268846A Cola for reinforcing human body phylactic power |
| 09/24/2008 | CN101268831A Truffle hydrophilic solvent extract and application of the same in preparing food, health food, and medicament for treating prostate gland disease etc. |
| 09/24/2008 | CN100420698C Process for extracting amygdalin and use thereof |
| 09/24/2008 | CN100420482C Method for short-term and long-term drug dosimetry |
| 09/24/2008 | CN100420448C Health-care food with function for improving immunity and its prepn. method |
| 09/24/2008 | CN100420440C Antiallergic agents, drugs, foods, drinks or cosmetics containing them and process for producing the same |
| 09/23/2008 | US7428705 Web map tool |
| 09/23/2008 | US7427681 Anticancer agents; antidiabetic agents; Alzheimer's disease |
| 09/23/2008 | US7427668 Polypeptide fusion comprising three nonoverlapping domains for use as tool in identifying modulator for enhancing immune response |
| 09/23/2008 | US7427660 Tumor antigen |
| 09/23/2008 | US7427655 Synthetic immunogenic but non amyloidogenic peptides homologous to amyloid β for induction of an immune response to amyloid β and amyloid deposits |
| 09/23/2008 | US7427631 especially as inhibitors of MMP12 |
| 09/23/2008 | US7427623 4-Amino-2,3-disubstituted thieno[2,3-d]pyrimidines and pharmacetical compositions thereof |
| 09/23/2008 | US7427613 7-aryl-3,9-diazabicyclo(3.3.1)non-6-ene derivatives and their use as renin inhibitors in the treatment of hypertension, cardiovascular or renal diseases |
| 09/23/2008 | US7427608 Protection against and treatment of hearing loss |
| 09/23/2008 | US7427591 Suppression of immune response via inhibition of cathepsin S |
| 09/23/2008 | US7427495 Enhancing or inhibiting apoptosis |
| 09/23/2008 | US7427418 Phloridzin-rich phenolic fraction and use thereof as a cosmetic, dietary or nutraceutical agent |
| 09/23/2008 | US7427403 Administering a soluble lymphotoxin- beta receptor, an antibody directed against LT- beta receptor, or an antibody directed against surface LT ligand with a carrier; multiple sclerosis, vision defects, psoriasis, inflammatory bowel disease; antidiabetic agents |
| 09/23/2008 | US7427397 Vitamin B12 supplement comprising Propionibacterium jensenii 702 together with a delivery agent; tuberculosis |
| 09/23/2008 | CA2432872C Pyrazole compounds useful as protein kinase inhibitors |
| 09/23/2008 | CA2418313C Piperidine derivatives and agent comprising the derivative as active ingredient |
| 09/23/2008 | CA2395541C New substituted piperidines, pharmaceutical compositions containing these compounds and processes for preparing them |
| 09/23/2008 | CA2379747C Novel succinate derivative compounds useful as cysteine protease inhibitors |
| 09/23/2008 | CA2375679C Methods and apparatus for relieving headaches, rhinitis and other common ailments |
| 09/23/2008 | CA2333323C Method and compositions for treatment of cancers |
| 09/23/2008 | CA2266479C Vitamin d analogues |
| 09/23/2008 | CA2259940C High-affinity interleukin-4 muteins |
| 09/23/2008 | CA2210109C Method to prevent transplant rejection |
| 09/23/2008 | CA2186004C Isolated peptides derived from mage tumor rejection antigen precursors which complex with hla-a2 molecules |
| 09/21/2008 | CA2637157A1 Mesenchymal stem cells and uses therefor |
| 09/18/2008 | WO2008112479A1 Salts of 3- (1h-ind0l-3-yl) -4- [2- (4-methyl-piperazin-i-yl) -quinazolin-4-yl] -pyrrole-2, 5-di one |
| 09/18/2008 | WO2008112325A2 Treatment of autoimmune disorders |
| 09/18/2008 | WO2008112257A1 Oligomer-antihistamine conjugates |
| 09/18/2008 | WO2008111526A1 Method for production of sugar oxazoline derivative |
| 09/18/2008 | WO2008111520A1 Gene related to life extension and use thereof |
| 09/18/2008 | WO2008111503A1 Protective agent for transplanted organ |
| 09/18/2008 | WO2008111450A1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/18/2008 | WO2008111430A1 METHOD FOR PRODUCING γδT CELL POPULATION |
| 09/18/2008 | WO2008111295A1 Agent for prevention and/or treatment of systemic lupus erythematosus |
| 09/18/2008 | WO2008109997A1 Procaspase 8-mediated disease targeting |
| 09/18/2008 | WO2008109992A1 Cytotoxicity mediation of cells evidencing surface expression of cd44 |
| 09/18/2008 | WO2008109943A1 Phenyl amino pyrimidine compounds and uses thereof |
| 09/18/2008 | WO2008109936A1 Steroidal compounds |
| 09/18/2008 | WO2008087441A3 An influenza prevention and treatment composition |
| 09/18/2008 | WO2008074803A3 4-benzyl-l ( 2h) -phthalazinones as h1 receptor antagonists |
| 09/18/2008 | WO2008014470A3 Adult sertoli cells and uses thereof |
| 09/18/2008 | US20080227983 Piperidine derivatives and process for their production |
| 09/18/2008 | US20080227957 Reducing Immunogenicities of Immunoglobulins by Framework-Patching |
| 09/18/2008 | US20080227869 Substituted nitrobenzene derivatives as pharmaceutical and other uses thereof |
| 09/18/2008 | US20080227858 as collagenase 1, 2 and 3, gelatinase A and B, stromelysin 1, 2 and 3, matrilysin, macrophage metalloelastase, enamelysin and membrane type 1, 2, 3 and 4 MMP; [(4'-Cyano-1,1'-biphenyl-4-yl)(methylsulfonyl)amino]acetic acid; antiinflammatory, anticarcinogenic agent, neurodegenerative diseases |
| 09/18/2008 | US20080227833 Selective inhibitors of MMP-9 and/or MMP12; antiinflammatory agents for multiple sclerosis and fibrosis; 3R-[2,2-Dimethyl-1 S-(5-phenyl-[1,2,4]oxadiazol-3-yl)-propylcarbamoyl]-2S-hydroxy-5-methyl-hexanohydroxamic acid; bone resorption, metastases, rheumatoid arthritis, Crohn's disease |
| 09/18/2008 | US20080227828 Aryl Ureas With Angiogenisis Inhibiting Activity |
| 09/18/2008 | US20080227798 inhibiting dipeptidyl peptidases; diabetes mellitus |
| 09/18/2008 | US20080227797 Pyridopyrimidine Derivatives as Pde4 Inhibitors for the Treatment of Inflammatory and Immune Diseases |
| 09/18/2008 | US20080227773 N-[4-(1,4-Diaza-bicyclo[3.2.2]non-4-yl)-phenyl]-benzamide; disorders related to smooth muscle contraction, endocrine diseases or disorders, diseases or disorders related to neuro-degeneration, diseases or disorders related to inflammation, pain, and withdrawal symptoms caused by the termination of abuse |
| 09/18/2008 | US20080227772 Diazabicyclic Aryl Derivatives as Nicotinic Acetylcholine Receptor Ligands |
| 09/18/2008 | US20080227761 Ameliorating a Th1 mediated immune pathology such as multiple sclerosis by raaising the serum concentration of estrogen to 30-1000 pg/ml by administering, e.g., 17-beta-estradiol, estriol or estrone; and administering a glatiramer acetate |
| 09/18/2008 | US20080227724 3-(alkanoyl or alkenoyl)amino-caprolactams; autoimmune diseases, asthma, osteoporosis, transplant rejection, psoriasis, Alzheimer's Disease, Multiple sclerosis, ALS; antitumor, antiarthritic, antifibrotic, and antiscarring agents |
| 09/18/2008 | US20080227719 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227718 administering to a patient an effective dosage of a polypeptide comprising an N-terminal segment of A beta , the segment beginning at residue 1-3 of A beta and ending at residues 7-11 of A beta to treat disease associated with amyloid deposit of A beta in the brain Alzheimer's disease, Down's syndrome |
| 09/18/2008 | US20080227717 Potent compstatin analogs |
| 09/18/2008 | US20080227714 Human Tumor Necrosis Factor TR18 and Methods Based Thereon |
| 09/18/2008 | US20080227703 neublastin neurotrophic factor polypeptides for treating neuropathy |
| 09/18/2008 | US20080227689 Autoimmune disorders; polypeptide GalNAc transferase 1 (ppGalNAcT-1) suppression; antisense RNA |